MitoChem Therapeutics

MitoChem Therapeutics Develops Treatments to Address the Role of Mitochondrial Dysfunction in Neurodegeneration, Aging, and Disease. Offers Mitoprotective Therapies for Eye and Neurodegenerative Disorders. With funding from Foundation Fighting Blindness and NIH, the company has synthesized compounds showing promise in treating vision loss associated with retinitis pigmentosa, age-related macular degeneration, and glaucoma.